Differential expression of suppressors of cytokine signaling-1, -2, and -3 in the rat hippocampus after seizure: Implications for neuromodulation by gp130 cytokines

Neuroscience

Volumn 122, Issue 2, 2003, Pages 349-358

  Rosell, D R ^a   Akama, K T ^a   Nacher, J ^b   Mcewen, B S ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

In situ hybridization; Lithium pilocarpine status epilepticus; Neuroprotection; SOCS

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 130; LITHIUM; PILOCARPINE; PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPILEPTIC STATE; FOLLOW UP; GRANULE CELL; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; SEIZURE; SIGNAL TRANSDUCTION;

EID: 0242570591     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00594-3     Document Type: Article

References (52)

1. Ali C., Nicole O., Docagne F., Lesne S., MacKenzie E.T., Nouvelot A., Buisson A., Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab. 20:2000;956-966.
2. Basu A., Krady J.K., O'Malley M., Styren S.D., DeKosky S.T., Levison S.W. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci. 22:2002;6071-6082.
3. Bellinger F.P., Madamba S.G., Campbell I.L., Siggins G.R. Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett. 198:1995;95-98.
4. Bensadoun J.C., de Almeida L.P., Dreano M., Aebischer P., Deglon N. Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome. Eur J Neurosci. 14:2001;1753-1761.
5. Bjorbaek C., Elmquist J.K., El-Haschimi K., Kelly J., Ahima R.S., Hileman S., Flier J.S. Activation of SOCS-3 messenger ribonucleic acid in the hypothalamus by ciliary neurotrophic factor. Endocrinology. 140:1999;2035-2043.
6. Bohannon N.J., Corp E.S., Wilcox B.J., Figlewicz D.P., Dorsa D.M., Baskin D.G. Localization of binding sites for insulin-like growth factor-I (IGF-I) in the rat brain by quantitative autoradiography. Brain Res. 444:1988;205-213.
7. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA. 90:1993;10061-10065.
8. Choi J.S., Kim S.Y., Cha J.H., Choi Y.S., Sung K.W., Oh S.T., Kim O.N., Chung J.W., Chun M.H., Lee S.B., Lee M.Y. Upregulation of gp130 and STAT3 activation in the rat hippocampus following transient forebrain ischemia. Glia. 41:2003;237-246.
9. D'Arcangelo G., Tancredi V., Onofri F., D'Antuono M., Giovedi S., Benfenati F. Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur J Neurosci. 12:2000;1241-1252.
10. Dey B.R., Spence S.L., Nissley P., Furlanetto R.W. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J Biol Chem. 273:1998;24095-24101.
11. Emanuelli B., Peraldi P., Filloux C., Chavey C., Freidinger K., Hilton D.J., Hotamisligil G.S., Van Obberghen E. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem. 276:2001;47944-47949.
12. Gadient R.A., Lein P., Higgins D., Patterson P.H. Effect of leukemia inhibitory factor (LIF) on the morphology and survival of cultured hippocampal neurons and glial cells. Brain Res. 798:1998;140-146.
13. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA. 93:1996;6231-6235.
14. Ginis I., Jaiswal R., Klimanis D., Liu J., Greenspon J., Hallenbeck J.M. TNF-alpha-induced tolerance to ischemic injury involves differential control of NF-kappaB transactivation the role of NF-kappaB association with p300 adaptor . J Cereb Blood Flow Metab. 22:2002;142-152.
15. Gloaguen I., Costa P., Demartis A., Lazzaro D., Di Marco A., Graziani R., Paonessa G., Chen F., Rosenblum C.I., Van der Ploeg L.H., Cortese R., Ciliberto G., Laufer R. Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. Proc Natl Acad Sci USA. 94:1997;6456-6461.
16. Gould E., McEwen B.S. Neuronal birth and death. Curr Opin Neurobiol. 3:1993;676-682.
17. Guo X., Chandrasekaran V., Lein P., Kaplan P.L., Higgins D. Leukemia inhibitory factor and ciliary neurotrophic factor cause dendritic retraction in cultured rat sympathetic neurons. J Neurosci. 19:1999;2113-2121.
18. Guthrie K.M., Woods A.G., Nguyen T., Gall C.M. Astroglial ciliary neurotrophic factor mRNA expression is increased in fields of axonal sprouting in deafferented hippocampus. J Comp Neurol. 386:1997;137-148.
19. Hama T., Kushima Y., Miyamoto M., Kubota M., Takei N., Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience. 40:1991;445-452.
20. Heinrich P.C., Behrmann I., Muller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J. 334:(Pt. 2):1998;297-314.
21. Hill J.M., Lesniak M.A., Kiess W., Nissley S.P. Radioimmunohistochemical localization of type II IGF receptors in rat brain. Peptides. 9:(Suppl 1):1988;181-187.
22. Honchar M.P., Olney J.W., Sherman W.R. Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science. 220:1983;323-325.
23. Jankowsky J.L., Patterson P.H. Differential regulation of cytokine expression following pilocarpine-induced seizure. Exp Neurol. 159:1999;333-346.
24. Justicia C., Gabriel C., Planas A.M. Activation of the JAK/STAT pathway following transient focal cerebral ischemia signaling through Jak1 and Stat3 in astrocytes . Glia. 30:2000;253-270.
25. Kar S., Seto D., Dore S., Chabot J.G., Quirion R. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation. Neuroscience. 80:1997;1041-1055.
26. Lebel E., Vallieres L., Rivest S. Selective involvement of interleukin-6 in the transcriptional activation of the suppressor of cytokine signaling-3 in the brain during systemic immune challenges. Endocrinology. 141:2000;3749-3763.
27. Levison S.W., Jiang F.J., Stoltzfus O.K., Ducceschi M.H. IL-6-type cytokines enhance epidermal growth factor-stimulated astrocyte proliferation. Glia. 32:2000;328-337.
28. Li A.J., Katafuchi T., Oda S., Hori T., Oomura Y. Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res. 748:1997;30-38.
29. Loddick S.A., Turnbull A.V., Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab. 18:1998;176-179.
30. Minami M., Kuraishi Y., Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun. 176:1991;593-598.
31. Murata S., Usuda N., Okano A., Kobayashi S., Suzuki T. Occurrence of a transcription factor, signal transducer and activators of transcription 3 (Stat3), in the postsynaptic density of the rat brain. Brain Res Mol Brain Res. 78:2000;80-90.
32. Planas A.M., Justicia C., Ferrer I. Stat1 in developing and adult rat brain induction after transient focal ischemia . Neuroreport. 8:1997;1359-1362.
33. Planas A.M., Soriano M.A., Berruezo M., Justicia C., Estrada A., Pitarch S., Ferrer I. Induction of Stat3, a signal transducer and transcription factor, in reactive microglia following transient focal cerebral ischaemia. Eur J Neurosci. 8:1996;2612-2618.
34. Polizzotto M.N., Bartlett P.F., Turnley A.M. Expression of "suppressor of cytokine signalling" (SOCS) genes in the developing and adult mouse nervous system. J Comp Neurol. 423:2000;348-358.
35. Reagan L.P., McKittrick C.R., McEwen B.S. Corticosterone and phenytoin reduce neuronal nitric oxide synthase messenger RNA expression in rat hippocampus. Neuroscience. 91:1999;211-219.
36. Ribak C.E., Dashtipour K. Neuroplasticity in the damaged dentate gyrus of the epileptic brain. Prog Brain Res. 136:2002;319-328.
37. Richter-Levin G., Canevari L., Bliss T.V. Long-term potentiation and glutamate release in the dentate gyrus links to spatial learning . Behav Brain Res. 66:1995;37-40.
38. Sarder M., Abe K., Saito H., Nishiyama N. Comparative effect of IL-2 and IL-6 on morphology of cultured hippocampal neurons from fetal rat brain. Brain Res. 715:1996;9-16.
39. Satoh M., Yoshida T. Promotion of neurogenesis in mouse olfactory neuronal progenitor cells by leukemia inhibitory factor in vitro. Neurosci Lett. 225:1997;165-168.
40. Schafer K.H., Mestres P., Marz P., Rose-John S. The IL-6/sIL-6R fusion protein hyper-IL-6 promotes neurite outgrowth and neuron survival in cultured enteric neurons. J Interferon Cytokine Res. 19:1999;527-532.
41. Sugiura S., Lahav R., Han J., Kou S.Y., Banner L.R., de Pablo F., Patterson P.H. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci. 12:2000;457-466.
42. Suzuki S., Tanaka K., Nogawa S., Dembo T., Kosakai A., Fukuuchi Y. Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats. Exp Neurol. 170:2001;63-71.
43. Takagi Y., Harada J., Chiarugi A., Moskowitz M.A. STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury. J Cereb Blood Flow Metab. 22:2002;1311-1318.
44. Tancredi V., D'Antuono M., Cafe C., Giovedi S., Bue M.C., D'Arcangelo G., Onofri F., Benfenati F. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J Neurochem. 75:2000;634-643.
45. Toulmond S., Vige X., Fage D., Benavides J. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett. 144:1992;49-52.
46. Vallieres L., Campbell I.L., Gage F.H., Sawchenko P.E. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci. 22:2002;486-492.
47. Wehinger J., Gouilleux F., Groner B., Finke J., Mertelsmann R., Weber-Nordt R.M. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett. 394:1996;365-370.
48. Wen T.C., Peng H., Hata R., Desaki J., Sakanaka M. Induction of phosphorylated-Stat3 following focal cerebral ischemia in mice. Neurosci Lett. 303:2001;153-156.
49. Wu Y.Y., Bradshaw R.A. Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J Biol Chem. 271:1996;13023-13032.
50. Xia X.G., Hofmann H.D., Deller T., Kirsch M. Induction of STAT3 signaling in activated astrocytes and sprouting septal neurons following entorhinal cortex lesion in adult rats. Mol Cell Neurosci. 21:2002;379-392.
51. Yamada M., Hatanaka H. Interleukin-6 protects cultured rat hippocampal neurons against glutamate-induced cell death. Brain Res. 643:1994;173-180.
52. Yasukawa H., Sasaki A., Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 18:2000;143-164.